Powering Precision Medicine Using Multi Level Data
Despite revealing tremendous insights into the cause and underlying mechanism of complex diseases such as cancer, cardiovascular disorders, neuropathological diseases, rare diseases etc., genomics alone often fails to identify important biomarkers for best therapy decisions. At this panel, we will explore with leading Swiss digital life science companies the advantages, promises but also obstacles of utilizing multi-molecular level data to advance precision medicine.
Abdullah Kahraman, Lecturer and Group Leader in Data Science in Life Sciences, FHNW Life Sciences
Moritz Kirschmann, Group Leader AI for Life Sciences, CSEM
Sarah Carl, Director of Data Science, Scailyte
Axel Martinelli, Head of Biology, BigOmics Analytics
Guillaume Cettou, Senior Director Business Development BioPharma, Sophia Genetics
Biotechnet is an association of Swiss Universities of Applied Sciences, Universities, and Research and Technology Organizations. We help industry access high-caliber competences in biotechnology at our member organizations. Industrial partners including small, medium and large enterprises can rely on our proven expertise and outstanding infrastructure to support innovative research & development projects. We are also a premium partner to address continuing education needs.